Income statement
USD
Annual
| Metric | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | -383 | 0 | 0 | -6K | 0 |
| Operating Income | -590K | -3M | -164K | -62K | -76K |
| EBITDA | -582K | 13M | -164K | -62K | -76K |
| Net Income | -993K | -14M | -164K | -62K | -76K |
| EPS (Diluted) | — | — | — | — | — |
Technology
Live Price
Offline$0.0001
+0.00% today
Window Change
+0.00%
Window
May 29, 2026 → Jun 18, 2026
Historical coverage is still filling in
This 1Y daily history view is currently sparse. Use it as directional context while we continue backfilling more history.
Coverage: 15 bars · May 29, 2026 → Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Valmie Resources, Inc. (VMRI) is a Technology stock with listed on OTC. The stock last traded around $0.00 and up 0.0% across the available one-year price window (May 29, 2026 → Jun 18, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of +89.9%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS +89.9%, free cash flow -13.7% with operating margin 0.0% and ROIC -235.2%. Stock Foundry combines VMRI price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Technology peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
VMRI
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
VMRI Max Drawdown
0.00%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for VMRI and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$0.0
FY Net Income
-$76.2K
-22.5% YoY
Free Cash Flow
-$36.5K
+48.1% YoY
Revenue Growth
+0.0%
EPS Growth
+89.9%
Gross Margin
0.0%
Net Margin
0.0%
Income statement
USD
| Metric | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | -383 | 0 | 0 | -6K | 0 |
| Operating Income | -590K | -3M | -164K | -62K | -76K |
| EBITDA | -582K | 13M | -164K | -62K | -76K |
| Net Income | -993K | -14M | -164K | -62K | -76K |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|
| Cash & Equivalents | 262K | 23K | 13K | 0 | 4K |
| Total Assets | 437K | 56K | 13K | 5K | 4K |
| Total Liabilities | 186K | 184K | 196K | 24K | 52K |
| Shareholder Equity | 251K | -128K | -183K | -19K | -48K |
| Total Debt | 0 | 123K | 68K | 7K | 0 |
| Net Debt | -262K | 100K | 55K | 7K | -4K |
Cash flow positioning
Latest Full Year
Operating Cash Flow
36K
+48.1% YoY
Capital Expenditures
0
Free Cash Flow
36K
+48.1% YoY
Key ratios
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-1614.5%
Debt / Equity
0.00x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.